28 related articles for article (PubMed ID: 31266439)
1. Point-of-care device for the noninvasive assessment of hepatic macrosteatosis in liver donors.
Rajamani AS; Rammohan A; J KS; Hakeem AR; Sai VVR; Vij M; Rela M
J Gastrointest Surg; 2024 Jun; 28(6):799-804. PubMed ID: 38570233
[TBL] [Abstract][Full Text] [Related]
2. Body Weight as a Preferred Method for Normalizing the Computed Tomography-Derived Liver Volume in Dogs without Hepatic Disease.
Kinoshita K; Moore G; Murakami M
Vet Sci; 2024 Mar; 11(4):. PubMed ID: 38668420
[TBL] [Abstract][Full Text] [Related]
3. Noninvasive Identification of Metabolic Dysfunction-associated Steatohepatitis Globally.
Reuter KL
Radiology; 2024 Mar; 310(3):e240436. PubMed ID: 38501949
[No Abstract] [Full Text] [Related]
4. The effect of hepatic steatosis on liver volume determined by proton density fat fraction and deep learning-measured liver volume.
Choi JY; Lee SS; Kim NY; Park HJ; Sung YS; Lee Y; Yoon JS; Suk HI
Eur Radiol; 2023 Sep; 33(9):5924-5932. PubMed ID: 37012546
[TBL] [Abstract][Full Text] [Related]
5. Noninvasive Estimation of Hepatic Steatosis by Controlled Attenuation Parameter in Living Donor Liver Transplant.
Eshraghian A; Fattahi MR; Mansourian M; Nikeghbalian S; Dehghani SM; Taghavi A; Kazemi K; Shamsaeefar A; Geramizadeh B; Malek-Hosseini SA
Exp Clin Transplant; 2022 Jul; 20(7):674-679. PubMed ID: 34546155
[TBL] [Abstract][Full Text] [Related]
6. Is Unenhanced Computed Tomography Reliable in the Assessment of Macrovesicular Steatosis in Living Liver Donors?
Haberal KM; Turnaoğlu H; Haberal Reyhan AN
Exp Clin Transplant; 2019 Dec; 17(6):749-752. PubMed ID: 31666000
[TBL] [Abstract][Full Text] [Related]
7. Role of Computed Tomography Volumetry in Estimating Liver Weights in Surgical Patients with Hepatic Steatosis.
Ha Y; Shim JH; Song GW; Kim SO; Ha TY; Jung DH; Kim KM; Lim YS; Lee HC; Lee SG
Exp Clin Transplant; 2017 Apr; 15(2):196-202. PubMed ID: 28338460
[TBL] [Abstract][Full Text] [Related]
8. Predicting Hepatic Steatosis in Living Liver Donors via Noninvasive Methods.
Kim JM; Ha SY; Joh JW; Sinn DH; Jeong WK; Choi GS; Gwak GY; Kwon CHD; Kim YK; Paik YH; Lee JH; Lee WJ; Lee SK; Park CK
Medicine (Baltimore); 2016 Feb; 95(7):e2718. PubMed ID: 26886612
[TBL] [Abstract][Full Text] [Related]
9. Noninvasive estimation of hepatic steatosis in living liver donors: usefulness of visceral fat area measurement.
Yamashiki N; Sugawara Y; Tamura S; Kaneko J; Matsui Y; Togashi J; Ohki T; Yoshida H; Omata M; Makuuchi M; Kokudo N
Transplantation; 2009 Aug; 88(4):575-81. PubMed ID: 19696642
[TBL] [Abstract][Full Text] [Related]
10. Hepatic Computed Tomography Volumetry for Noninvasive Detection of Hepatic Steatosis and Steatohepatitis in Living Liver Donors.
Eshraghian A; Rasekhi A; Nikeghbalian S; Muhammad S; Kazemi K; Jalaeian H; Shamsaeefar A; Geramizadeh B; Malek-Hosseini SA
Exp Clin Transplant; 2022 Apr; 20(4):388-394. PubMed ID: 31266439
[TBL] [Abstract][Full Text] [Related]
11. Section 1. Image evaluation of fatty liver in living donor liver transplantation.
Cheng YF; Yu CY; Ou HY; Tsang LL; Huang TL; Chen TY; Concejero A; Wang CC; Wang SH; Lin TS; Liu YW; Yang CH; Yong CC; Chiu KW; Jawan B; Eng HL; Chen CL
Transplantation; 2014 Apr; 97 Suppl 8():S3-6. PubMed ID: 24849828
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of living liver donors.
Chen YS; Cheng YF; De Villa VH; Wang CC; Lin CC; Huang TL; Jawan B; Chen CL
Transplantation; 2003 Feb; 75(3 Suppl):S16-9. PubMed ID: 12589132
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
